EA can effectively reduce the levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-18 (IL-18), and tumor necrosis factor-α (TNF-α), helping to inhibit the inflammatory response in a variety of neurological diseases [15–17]. Here, IL18 is linked to nervous system disorder.